Since its launch in January 2009, Genome Medicine has acted as a forum for reporting and discussing  some of the most exciting research in the evolving field of genomic medicine. To mark its second anniversary, the section editors of Genome Medicine collaborated to produce an Editorial in which they review some of the breakthroughs made in the field over the last two years.

This perspective piece discusses advances in translational medicine, personalized medicine, technologies, bioinformatics and disease management and therapeutics. The editors comment on the strengths and limitations of current research and the direction in which the field of genomic medicine is heading.

We have no doubt that researchers around the world will continue to generate intriguing and groundbreaking insights into this exciting area, and we welcome manuscript submissions reporting outstanding research within this scope. Genome Medicine also publishes reviews, meeting reports and commentaries by leading experts in the field; sign up for article alerts and follow us on twitter.

We hope that you will enjoy this special editorial and would like to thank you for supporting the journal for the past two years. We look forward to bringing you the best in genomic medicine research in 2011.